March 29, 2017
38,205
2,204
391
6.79%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:03Now PlayingA synthetic marijuana product could be available for commercialization after the DEA gave a newly approved drug a schedule II classification.
On Thursday, Insys Therapeutics announced that the Drug Enforcement Administration (DEA) issued an interim final rule that would put Syndros, their synthetic marijuana drug, on Schedule II of the Controlled Substances Act (CSA)...
Read More At:
Follow Kyle on Twitter:
Here's The Secular Talk Amazon Link:
Like the show on Facebook:
Clip from The Kyle Kulinski Show, which airs live on Blog Talk Radio and Secular Talk Radio Monday - Friday 11:00 AM - 12:30 PM Eastern time zone.
Listen to the Live Show or On Demand archive at:
Check out our website - and become a member - at:
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.